What are the causes of hyperchloremic metabolic acidosis?

Causes of Hyperchloremic Metabolic Acidosis

Hyperchloremic metabolic acidosis results from three primary mechanisms: excessive chloride administration (most commonly from 0.9% saline infusions), gastrointestinal bicarbonate losses, or renal tubular acidosis with impaired acid excretion or bicarbonate reabsorption.

Iatrogenic Causes (Most Common in Clinical Practice)

Excessive Saline Administration

The most frequent cause in hospitalized patients is administration of large volumes of 0.9% normal saline, which contains 154 mEq/L of chloride 1, 2, 3. This mechanism operates through the Stewart approach to acid-base balance: when plasma chloride increases relative to sodium, the strong ion difference (SID) decreases, which directly lowers pH and bicarbonate concentration 4.

• Perioperative settings: Patients receiving aggressive fluid resuscitation during surgery commonly develop hyperchloremic acidosis 1
• Critical care: Septic shock resuscitation with normal saline consistently produces this complication 2, 5, 6
• Dose-response relationship: Base excess changes by approximately -0.4 mmol/L for each mmol/kg of chloride administered 6
• Temporal pattern: In pediatric meningococcal sepsis, hyperchloremic acidosis becomes the dominant acidosis by 8-12 hours post-resuscitation, replacing the initial unmeasured anion acidosis 6

Clinical pearl: The acidosis from saline is transient and resolves with adequate urine output and renal chloride excretion 7. However, it can mask resolution of the underlying condition (e.g., DKA) and lead to unnecessarily prolonged treatment 8.

Surgical Irrigation Fluid Absorption

Absorption of saline during transurethral procedures (laser enucleation of prostate, bladder resection) can cause severe hyperchloremic acidosis, particularly when bladder perforation occurs 9.

Gastrointestinal Causes

Diarrhea and Intestinal Losses

Bicarbonate-rich fluid losses from the gastrointestinal tract cause hyperchloremic acidosis through two mechanisms:

• Direct bicarbonate loss (small bowel, pancreatic, biliary secretions contain high bicarbonate)
• Compensatory chloride retention by the kidney to maintain extracellular volume 10

Specific conditions include:

• Severe diarrhea (any etiology)
• Ileostomy or colostomy with high output 4
• Congenital chloride diarrhea: Presents with pronounced hypokalemic, hypochloremic metabolic alkalosis (not acidosis) but mentioned for differential diagnosis 11
• Bowel obstruction with sequestration 4

Urinary Diversions

Ureterosigmoidostomy or ileal conduits allow urinary chloride reabsorption and bicarbonate secretion into urine.

Renal Causes

Renal Tubular Acidosis (RTA)

All forms of RTA produce hyperchloremic normal anion gap metabolic acidosis through defective renal acidification 10, 12:

Type 1 (Distal) RTA:

• Impaired distal tubular hydrogen ion secretion
• Inability to acidify urine below pH 5.5
• Associated with nephrocalcinosis, hypokalemia
• Can present with kidney stones in young patients 11

Type 2 (Proximal) RTA:

• Defective proximal tubular bicarbonate reabsorption
• Bicarbonate wasting in urine when serum levels normalize
• Often part of Fanconi syndrome

Type 4 RTA:

• Aldosterone deficiency or resistance
• Characterized by hyperkalemia (distinguishing feature)
• Common in diabetic nephropathy, chronic kidney disease
• Medications: ACE inhibitors, ARBs, potassium-sparing diuretics, calcineurin inhibitors 12

RTA of renal insufficiency:

• Occurs with moderate CKD (GFR 20-50 mL/min)
• Initially presents as normal anion gap acidosis
• Progresses to high anion gap acidosis with severe renal failure 10

Kidney Transplant Patients

All RTA types occur in transplant recipients due to 12:

• Reduced renal mass
• Calcineurin inhibitor toxicity (cyclosporine, tacrolimus)
• Renin-angiotensin-aldosterone system blockers
• Acute or chronic rejection
• Hyperparathyroidism

Medication-Induced Causes

Beyond saline administration:

• Acetazolamase (carbonic anhydrase inhibitor): Causes proximal bicarbonate wasting
• Topiramate: Carbonic anhydrase inhibition
• Potassium-sparing diuretics: Type 4 RTA pattern
• Calcineurin inhibitors: Multiple RTA mechanisms 12
• Total parenteral nutrition: Excessive chloride from amino acid solutions, calcium chloride, normal saline 4

Diabetic Ketoacidosis Treatment Complication

During DKA treatment, hyperchloremic acidosis develops in 69.3% of patients by mean 6.3 hours, with incidence increasing to 80% by 24 hours 8. This occurs because:

• Ketoanions are excreted as sodium/potassium salts during osmotic diuresis
• Chloride from IV fluids replaces lost ketoanions
• Can mask DKA resolution when monitoring only pH and bicarbonate

Critical distinction: Monitor anion gap and chloride-corrected bicarbonate to differentiate persistent DKA from iatrogenic hyperchloremic acidosis 7, 8.

Diagnostic Approach

Calculate urine anion gap or osmolal gap to distinguish renal from extrarenal causes 10:

• Positive urine anion gap: Renal acidosis (RTA) - impaired ammonium excretion
• Negative urine anion gap: Extrarenal acidosis (GI losses) - appropriate renal response with increased ammonium excretion

Assess serum potassium:

• Hypokalemia: Types 1,2 RTA, or GI losses
• Hyperkalemia: Type 4 RTA (narrows differential significantly)

Fractional chloride excretion:

• Elevated (>0.5%): Renal salt wasting (e.g., Bartter syndrome - though this causes alkalosis, not acidosis) 11
• Low: Appropriate renal chloride retention in response to GI losses

Clinical Significance

Hyperchloremic acidosis is not benign 1, 2, 3:

• Reduces gastric blood flow and mucosal pH
• Impairs gastric motility
• Decreases renal blood flow and GFR
• May increase vasopressor requirements
• Associated with worse outcomes in critically ill patients

However, recent evidence suggests hyperchloremic metabolic acidosis may respond better to sodium bicarbonate therapy than other forms of metabolic acidosis, particularly when chloride ≥112 mmol/L 13.